Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977917 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL7914906 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL788641 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL25206528 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL198354 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL23234144 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL18970877 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL23016820 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL61278 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 | |
| SCHEMBL31314689 | 1.00 | EPHX2 (0.41) | EPHX2MEN1KMT2AFFAR4FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110160660-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. | 2011-06-30 | — | — | US | claimed |
| EP-3854428-B1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX INC (US) | 2025-07-30 | — | — | EP | disclosed |
| US-11975161-B2 | Drug releasing coatings for balloon catheters | LUTONIX, INC. (US) | 2024-05-07 | — | — | US | disclosed |
| US-20230277818-A1 | DRUG RELEASING COATINGS FOR BALLOON CATHETERS | LUTONIX, INC. (US) | 2023-09-07 | — | — | US | disclosed |
| EP-3378506-B1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX INC (US) | 2023-06-07 | — | — | EP | disclosed |
| US-20230165840-A1 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | LUTONIX, INC. (US) | 2023-06-01 | — | — | US | disclosed |
| US-11633359-B2 | Method for producing organic material microparticles, and method for modifying organic material microparticles | M. TECHNIQUE CO., LTD. (JP) | 2023-04-25 | — | — | US | disclosed |
| US-11534430-B2 | Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs | LUTONIX, INC. (US) | 2022-12-27 | — | — | US | disclosed |
| US-20220296863-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. (US) | 2022-09-22 | — | — | US | disclosed |
| US-11376404-B2 | Drug releasing coatings for medical devices | LUTONIX, INC. (US) | 2022-07-05 | — | — | US | disclosed |
| WO-2011119159-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | WANG LIXIAO (US) | 2011-09-29 | — | — | WO | disclosed |
| US-20110160660-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. | 2011-06-30 | — | — | US | disclosed |
| EP-2241341-A2 | Drug releasing coatings for medical devices | Lutonix, Inc. (US) | 2010-10-20 | — | — | EP | disclosed |
| US-20100209472-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. | 2010-08-19 | — | — | US | disclosed |
| WO-2010077598-A1 | LOW TOTAL SALT REAGENT COMPOSITIONS AND SYSTEMS FOR BIOSENSORS | BAYER HEALTHCARE LLC (US) | 2010-07-08 | — | — | WO | disclosed |
| EP-2073860-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | Lutonix, Inc. (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2009051618-A1 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | LUTONIX, INC. (US) | 2009-04-23 | — | — | WO | disclosed |
| WO-2009051614-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. (US) | 2009-04-23 | — | — | WO | disclosed |
| US-20080276935-A1 | TREATMENT OF ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-PROLIFERATE AND ANTI-INFLAMMATORY DRUGS | LUTONIX, INC. | 2008-11-13 | — | — | US | disclosed |
| US-20080255508-A1 | Such as balloon and stents; medical device with overcoating of drug with additive; bioavailability | LUTONIX, INC. | 2008-10-16 | — | — | US | disclosed |